TSHA - Taysha Gene Therapies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$15.00
LOW:
$13.00
MEDIAN:
$14.00
CONSENSUS:
$14.00
UPSIDE:
153.62%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-10 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 200,000 | $6.24 | $1.2M |
| 2026-06-01 | Stalfort John A III | director | A-Award | 21,335 | -- | -- |
| 2026-06-01 | Donenberg Phillip B. | director | A-Award | 42,671 | $5.97 | $255K |
| 2026-06-01 | Sepp-Lorenzino Laura | director | A-Award | 21,335 | -- | -- |
| 2026-06-01 | Sepp-Lorenzino Laura | director | A-Award | 42,671 | $5.97 | $255K |
| 2026-06-01 | Donenberg Phillip B. | director | A-Award | 21,335 | -- | -- |
| 2026-06-01 | Stalfort John A III | director | A-Award | 42,671 | $5.97 | $255K |
| 2026-06-01 | Long Alison S | director | A-Award | 21,335 | -- | -- |
| 2026-06-01 | Long Alison S | director | A-Award | 42,671 | $5.97 | $255K |
| 2026-04-10 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 200,000 | $4.46 | $892K |
| 2026-04-10 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 19,021 | $1.71 | $33K |
| 2026-02-04 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | SELL | 1,655 | $4.52 | $7K |
| 2026-01-26 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | SELL | 23,849 | $4.61 | $110K |
| 2026-01-23 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | SELL | 78,968 | $4.75 | $375K |
| 2026-01-26 | Nolan Sean P. | director, officer: Chief Executive Officer | SELL | 41,312 | $4.61 | $190K |
| 2026-01-23 | Nolan Sean P. | director, officer: Chief Executive Officer | SELL | 136,789 | $4.75 | $650K |
| 2026-01-23 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 89,132 | $4.75 | $423K |
| 2026-01-26 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 26,918 | $4.61 | $124K |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | A-Award | 274,000 | $4.86 | $1.3M |
| 2026-01-12 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | A-Award | 359,000 | -- | -- |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 200,000 | $4.71 | $942K |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 88,676 | $1.71 | $152K |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 111,324 | $0.70 | $78K |
| 2026-01-12 | Nolan Sean P. | director, officer: Chief Executive Officer | A-Award | 1,008,000 | -- | -- |
| 2026-01-12 | Nolan Sean P. | director, officer: Chief Executive Officer | A-Award | 648,000 | $4.86 | $3.1M |